March 25, 2015

The SWENOTECA now starts inclusion in the ABC-study. This is a randomized phase III study in stage I seminomatous testicular cancer. Patients with one or two risk factors (stromal invasion of the rete testis and/or tumor size over 4 cm) will be randomized between one c...

February 25, 2015

Welcome to this years annual meeting in Trondheim.

 

Invitation and program.

 

October 15, 2014

Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.

Cohn-Cedermark G, Stahl O, Tandstad T; SWENOTECA.

Andrology. 2014 Oct 1. doi: 10.1111/andr.280. [Epub ahead of print]

 

Although clinical stage I...

October 1, 2014

In the last months several new articles have been published by or in collaboration with SWENOTECA .

 

One Course of Adjuvant BEP in Clinical Stage I Nonseminoma Mature and Expanded Results from the SWENOTECA group. Ann Oncol. 2014 Aug 11. pii: mdu375. [Epub ahead of prin...

October 1, 2014

A new protocol for seminoma is now available. It replaces SWENOTECA VII from  October 1, 2014.

The major changes in the guideline are:

  • Stage I:

    • Patients with tumour size 4 cm or less and without invasion of the rete testis are recommended surveillance....

Please reload

Recent Posts

May 20, 2020

March 30, 2020

March 1, 2019

October 30, 2015

April 9, 2015

Please reload

Archive
Please reload

​​​Contact Us

SWENOTECA

Kreftklinikken, St. Olavs Hospital,

Postboks 3250 Sluppen

7006 Trondheim, Norway

Follow Us

  • w-facebook

swenoteca.org

 © 2015 SWENOTECA